Target | Drug name | Cancer | Phase | ClinicalTrials.gov Identifier |
---|---|---|---|---|
Mir 16 | TargomiRs | Malignant pleura mesothelioma, Non small-cell lung cancer | I | NCT02369198 |
Mir 155 | MRG 106 | Lymphomas, Leukemia | I | NCT02580552 |
Mir 34a | MRX34 | Melanoma, Primary liver cancer; Hematologic malignancies | I Terminated | NCT01829971 |
Mir 34a | MRX34 | Melanoma, Primary liver cancer; Hematologic malignancies | I/II Withdrawn | NCT02862145 |